| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +100.00% | -9.17% | +0.45% | -9.62% | -11.27% | — |
| 14d | 3 | +66.67% | -13.21% | +0.34% | -13.55% | -11.35% | — |
| 30d | 3 | +100.00% | -22.14% | +1.58% | -23.72% | -21.69% | — |
| 60d | 3 | +100.00% | -9.25% | +5.01% | -14.26% | -14.17% | — |
| 90d | 3 | +100.00% | -9.66% | +6.95% | -16.62% | -16.07% | — |
| 180d | 3 | +100.00% | -20.08% | +9.23% | -29.31% | -30.89% | — |
| 1y | 3(2 pending) | +0.00% | +63.93% | +20.53% | +43.40% | +43.40% | — |
| 2y | 3(3 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE10b5-1 10b5-1 plan | 220,426 | $3.99 | $879.5K | 1,390,056 | May 28, 2026 | May 28, 2026 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE CEO, Counterpart Health | 23,463 | $2.04 | $47.9K | 1,169,914 | Apr 15, 2026 | Apr 16, 2026 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | PURCHASEGRANT Stock grant | 267,766 | — | — | 1,193,377 | Apr 1, 2026 | Apr 3, 2026 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE CEO, Counterpart Health | 100,195 | $1.98 | $198.4K | 925,611 | Mar 14, 2026 | Mar 17, 2026 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE CEO, Counterpart Health | 25,868 | $2.81 | $72.7K | 1,025,806 | Jan 15, 2026 | Jan 20, 2026 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE CEO, Counterpart Health | 98,411 | $2.70 | $265.7K | 1,051,674 | Dec 14, 2025 | Dec 16, 2025 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE CEO, Counterpart Health | 96,448 | $3.53 | $340.5K | 1,178,015 | Oct 31, 2025 | Nov 4, 2025 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE CEO, Counterpart Health | 27,930 | $3.53 | $98.6K | 1,150,085 | Oct 31, 2025 | Nov 4, 2025 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE CEO, Counterpart Health | 92,181 | $2.80 | $258.1K | 1,274,463 | Oct 15, 2025 | Oct 17, 2025 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE CEO, Counterpart Health | 98,412 | $3.06 | $301.1K | 1,573,425 | Sep 14, 2025 | Sep 16, 2025 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE CEO, Counterpart Health | 27,930 | $2.89 | $80.7K | 1,671,837 | Jul 31, 2025 | Aug 4, 2025 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE10b5-1 10b5-1 plan | 91,197 | $3.32 | $302.8K | 1,403,701 | Jul 23, 2025 | Jul 24, 2025 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE10b5-1 10b5-1 plan | 118,600 | $3.29 | $390.2K | 1,494,898 | Jul 22, 2025 | Jul 24, 2025 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE10b5-1 10b5-1 plan | 15,203 | $3.26 | $49.6K | 1,613,498 | Jul 8, 2025 | Jul 10, 2025 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE CEO, Counterpart Health | 98,411 | $2.89 | $284.4K | 3,138,535 | Jun 14, 2025 | Jun 17, 2025 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE CEO, Counterpart Health | 26,593 | $3.40 | $90.4K | 3,236,946 | Apr 30, 2025 | May 2, 2025 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE CEO, Counterpart Health | 80,524 | $3.66 | $294.7K | 3,263,539 | Mar 14, 2025 | Mar 18, 2025 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE CEO, Counterpart Health | 24,470 | $4.39 | $107.4K | 3,344,063 | Jan 31, 2025 | Feb 4, 2025 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE CEO, Counterpart Health | 98,217 | $3.11 | $305.5K | 3,368,533 | Dec 14, 2024 | Dec 17, 2024 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE CEO, Counterpart Health | 111,496 | $4.12 | $459.4K | 3,466,750 | Oct 31, 2024 | Nov 4, 2024 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | PURCHASEGRANT Stock grant | 726,114 | — | — | 3,578,246 | Oct 15, 2024 | Oct 17, 2024 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE Chief Technology Officer | 98,217 | $2.99 | $293.7K | 2,852,132 | Sep 14, 2024 | Sep 17, 2024 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | PURCHASEGRANT Stock grant | 379,866 | — | — | 1,699,767 | Sep 13, 2024 | Jul 10, 2025 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | PURCHASEGRANT Stock grant | 189,934 | — | — | 3,043,529 | Sep 13, 2024 | Sep 17, 2024 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE Chief Technology Officer | 93,180 | $2.99 | $278.6K | 2,950,349 | Sep 13, 2024 | Sep 17, 2024 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE Chief Technology Officer | 69,148 | $1.09 | $75.4K | 2,853,595 | Jun 14, 2024 | Jun 18, 2024 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE Chief Technology Officer | 74,396 | $0.73 | $54.3K | 2,922,743 | Mar 14, 2024 | Mar 18, 2024 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE Chief Technology Officer | 96,086 | $1.00 | $96.1K | 2,997,139 | Dec 14, 2023 | Dec 18, 2023 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | PURCHASEGRANT Stock grant | 440,000 | — | — | 3,093,225 | Oct 31, 2023 | Nov 3, 2023 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE Chief Technology Officer | 96,086 | $1.13 | $108.6K | 2,653,225 | Sep 14, 2023 | Sep 18, 2023 ↗ | View → |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SALE Chief Technology Officer | 86,763 | $0.94 | $81.6K | 2,749,311 | Jun 14, 2023 | Jun 16, 2023 ↗ | View → |